A.   Continue to monitor consciousness for 2 minutes.

B.   Provide another prescribed medication.

C.   Administer a second dose.

D.   Administer four doses at 15-second intervals.

A.   Eszopiclone

B.   Zolpidem

C.   Ramelteon

D.   Zaleplon

A.   Deep sleep

B.   Dozing

C.   Sleepwalking

D.   Relaxation

A.   Vivid dreams

B.   Daytime fatigue

C.   Bedwetting

D.   Sleepwalking

A.   Intermediate-acting barbiturates

B.   Ultra-short-acting barbiturates

C.   Long-acting barbiturates

D.   Short-acting barbiturates

A.   Cardiac disease

B.   Epileptic disease

C.   Narrow-angle glaucoma

D.   Drug allergy

A.   Reduction of choreiform movement

B.   Relief of nerve pain

C.   Reduction of muscle rigidity

D.   Prevention of lightheadedness

A.   Bedwetting

B.   Increased perspiration

C.   Increased body weight

D.   Sleepwalking

A.   Ramelteon

B.   Midazolam

C.   Eszopiclone

D.   Alprazolam

A.   Dantrolene

B.   Cyclobenzaprine

C.   Baclofen

D.   Diazepam

A.   Constipation

B.   Decreased heart rate

C.   Dry mouth

D.   Amnesia

A.   Verapamil

B.   Rifampin

C.   Olanzapine

D.   Flumazenil

A.   The drug acts on gamma-aminobutyric acid (GABA) receptors in the central nervous system (CNS).

B.   The patient may need to be sedated to relieve symptoms of alcohol withdrawal.

C.   The drug may reduce the memory of painful symptoms related to alcohol withdrawal.

D.   The drug acts on benzodiazepine receptors that play a role in alcohol addiction.

A.   Oxytocin

B.   Ceftriaxone

C.   Sulfamethoxazole

D.   Phenobarbital

A.   Pentobarbital

B.   Butabarbital

C.   Mephobarbital

D.   Phenobarbital

A.   Prolonged benzodiazepine action

B.   Increased daytime sleepiness

C.   Decreased benzodiazepine effects

D.   Increased central nervous system (CNS) depression

A.   Activated charcoal

B.   Furosemide

C.   Olanzapine

D.   Flumazenil

A.   Presence of benzodiazepine receptors adjacent to the receptors responsible for alcohol addiction

B.   Suppression of gamma-aminobutyric acid (GABA) receptors

C.   Inhibition of nerve impulse transmission

D.   Amnesic properties

A.   Encouraging the patient to maintain a well-balanced diet

B.   Recommending that the patient consume a glass of warm lactose-free milk at bedtime

C.   Teaching the patient about meditation

D.   Instructing the patient to take low doses of benzodiazepines

A.   Flumazenil at a maximum dose of 1 mg

B.   Flumazenil at a maximum dose of 3 mg

C.   Phenylephrine at a maximum dose of 5 mg

D.   Phenylephrine at a maximum dose of 2 mg

A.   The patient is experiencing a muscle-relaxant overdose.

B.   The patient is experiencing a barbiturate overdose.

C.   The patient was administered azole along with benzodiazepine.

D.   The patient is experiencing benzodiazepine toxicity.

A.   Diazepam

B.   Pentobarbital

C.   Zaleplon

D.   Ramelteon

A.   Establishing a set sleep pattern

B.   Sleeping more during the day

C.   Avoiding tobacco at bedtime

D.   Avoiding alcohol at bedtime

A.   Diazepam

B.   Temazepam

C.   Midazolam

D.   Flurazepam

A.   Alertness

B.   Hallucinations

C.   Ataxia

D.   Dyspnea

A.   Naloxone

B.   Flumazenil

C.   Ipecac syrup

D.   Activated charcoal

A.   Degree of patient responsiveness to the drug given

B.   Degree of inhibition of nerve impulse transmission to the CNS

C.   Dose of the drug used to produce the effect on the CNS

D.   Duration of action on the central nervous system (CNS)

A.   The therapeutic activity of temazepam is reduced with sleep.

B.   Temazepam causes early awakening after sleep.

C.   Temazepam may cause gastrointestinal upset.

D.   Temazepam induces sleep in approximately 1 hour.

A.   Infusion that is too rapid

B.   Infusion of other drugs

C.   Intravenous infiltration

D.   Infusion without dilution

A.   Take lower doses of benzodiazepines.

B.   Go to acupuncture therapy.

C.   Drink lactose-free milk at bedtime.

D.   Use home remedies of vegetables and herbs.

A.   Diazepam, Ramelteon, Midazolam

B.   Zolpidem, Diazepam, Midazolam

C.   Diazepam, Midazolam, Eszopiclone

D.   Zolpidem, Ramelteon, Eszopiclone

A.   Maintenance of an adequate airway

B.   Administration of furosemide

C.   Administration of activated charcoal

D.   Administration of intravenous fluids

A.   "I will stop drinking coffee at least 6 hours before bedtime."

B.   "I may be prescribed benzodiazepines to promote sleep."

C.   "I should avoid exercise just before going to bed."

D.   "I will have a glass of warm milk before bed."

A.   Request a prescription to increase the dosage of pentobarbital.

B.   Instruct the patient to increase the dosage of the contraceptive drug.

C.   Recommend discussing an alternative drug for seizures with the primary health care provider.

D.   Suggest an alternate contraceptive method to the patient.

A.   Respiratory arrest

B.   Malignant hyperthermia

C.   Delirium tremens

D.   Tonic-clonic seizure

A.   Avoid using this drug to induce sleep.

B.   Take the drug 30 minutes before sleeping.

C.   Drink coffee or tea in the morning.

D.   Use the lowest effective dosage.

A.   Produces drowsiness, lethargy, and blurred vision

B.   Causes gastrointestinal distress

C.   Impairs coordinated movements

D.   Increases pain associated with activities

A.   Thiopental

B.   Phenobarbital

C.   Butabarbital

D.   Pentobarbital

A.   Pregnancy, Drug allergy, Significant respiratory difficulties

B.   Significant respiratory difficulties, Hypotension, Status epilepticus

C.   Hypotension, Drug allergy, Status epilepticus

D.   Hypotension, Status epilepticus, Pregnancy

A.   "Report palpitations to the primary health care provider."

B.   "Allow at least 8 hours for sleep."

C.   "Take the medication with food or milk."

D.   "Expect and prepare for a daytime hangover."

A.   Takes olanzapine along with diazepam

B.   Drinks grapefruit juice along with diazepam

C.   Takes phenobarbital along with diazepam

D.   Takes rifampin along with diazepam

A.   Tricyclic antidepressant, Monoamine oxidase inhibitor (MAOI), Atypical antidepressants

B.   Selective serotonin reuptake inhibitor (SSRI), Tricyclic antidepressant, Serotonin-norepinephrine reuptake inhibitor (SNRI)

C.   Monoamine oxidase inhibitor (MAOI), Selective serotonin reuptake inhibitor (SSRI), Serotonin-norepinephrine reuptake inhibitor (SNRI)

D.   Selective serotonin reuptake inhibitor (SSRI), Serotonin-norepinephrine reuptake inhibitor (SNRI), Atypical antidepressants

A.   Bronchial asthma

B.   Liver dysfunction

C.   Kidney dysfunction

D.   Narrow-angle glaucoma

A.   Clonazepam

B.   Temazepam

C.   Eszopiclone

D.   Alprazolam

A.   Pentobarbital

B.   Diazepam

C.   Baclofen

D.   Zaleplon

A.   Monitoring the patient’s renal and hepatic function

B.   Monitoring for suicidal tendencies

C.   Assessing the patient’s risk for injury or falls

D.   Encouraging the patient to drink more fluids

A.   Airway maintenance

B.   Antidote preparation

C.   Comfort measures

D.   Seizure precautions

A.   Amount of bleeding

B.   Indicators of infection

C.   Muscle spasms

D.   Level of consciousness

A.   0.2 mg (2 mL) of flumazenil was given intravenously (IV).

B.   The half-life of flumazenil is short.

C.   A high dose of flumazenil was given.

D.   Alcohol was consumed with the benzodiazepines.

A.   Zaleplon

B.   Alprazolam

C.   Eszopiclone

D.   Ramelteon

A.   "I often feel dizzy and lightheaded."

B.   "I feel like I breathe too deeply."

C.   "I sleep less than I used to."

D.   "Nowadays I sleep for long hours."

A.   0.2 mg (2 mL) intravenously (IV) over 30 seconds

B.   0.2 mg (2 mL) IV over 15 seconds

C.   0.2 mg (2 mL) IV over 60 seconds

D.   0.5 mg (5 mL) IV over 30 seconds